Mirum Pharmaceuticals said on Monday its experimental drug, volixibat, met the main goal of a mid-stage study by reducing severe itching or pruritus in patients with a…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/mirums-rare-liver-disease-drug-meets-main-goal-mid-stage-2026a1000e8t?src=rss
Author :
Publish date : 2026-05-04 18:04:00
Copyright for syndicated content belongs to the linked Source.
